Tumoral ANXA1 Is a Predictive Marker for Sunitinib Treatment of Renal Cancer Patients

Marjut Niinivirta,Gunilla Enblad,Per-Henrik Edqvist,Fredrik Pontén,Anca Dragomir,Gustav Ullenhag

Tumoral ANXA1 Is a Predictive Marker for Sunitinib Treatment of Renal Cancer Patients

2017

Marjut Niinivirta
Gunilla Enblad
Per-Henrik Edqvist
Fredrik Pontén
Anca Dragomir
Gustav Ullenhag

Background and aims: There is no established predictive marker for the treatment of renal cancer. Metastatic renal cell carcinoma (mRCC) patients are often treated with sunitinib, a tyrosine kinase ...

Keywords:

Predictive marker
Cancer
Tyrosine kinase
Pathology
Cancer research
Oncology
Renal cell carcinoma
Sunitinib
Internal medicine
Medicine
Tissue microarray
Text mining

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations